Manchester-based mid-market financial advisory group Altium has agreed a merger worth more than £250m with a global investment bank.
Altium has entered into a definitive merger agreement with GCA Savvian Corporation to form GCA, which aims to be the “pre-eminent global investment bank focused on growth companies”. GCA will operate under the names GCA Altium in Europe and GCA in the US.
Upon completion of the transaction, the merged company will have more than $185m (£128m) in advisory revenues, employ approximately 370 staff across 14 locations in ten countries, have generated revenues of more than £120m in 2015, and have completed more than 315 transactions over the last three years.
GCA will have offices in Manchester, London, Tokyo, San Francisco, New York, Osaka, Shanghai, Singapore, Mumbai, Frankfurt, Munich, Zurich, Milan and Tel Aviv. It will provide clients with a broad range of investment banking services including M&A, capital markets, capital raising services for fund managers, debt advisory and private capital raising.
Manchester-based Phil Adams (pictured), chief executive of Altium, said: “Our merger with GCA Savvian marks a key step in our growth strategy.
“Now, more than ever before, business owners and entrepreneurs are looking for international M&A opportunities and this move will provide us with experts in all corners of the globe. The strong global coverage of the newly formed group will enable us to provide the best possible service to our clients.”
Full Content: Business Standard
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Rumble Adds David Boies to Legal Team in $2 Billion Antitrust Battle with Google
May 14, 2025 by
CPI
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Judge Orders Sanctions Against Missouri for Noncompliance in Price-Fixing Probe
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas